# Aakha Biologics, Inc. — Form D

Aakha Biologics, Inc. of FRISCO, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-17. The offering totals $5.0M, of which $750K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-07-17
- Form: D
- Accession: 0002030720-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $750K
- Remaining: $4.3M
- Investors: 1
- Date of first sale: 2024-07-02
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-519031

## Issuer

- Name: Aakha Biologics, Inc.
- CIK: 0002030720
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 5680 FRISCO SQ. BLVD., FRISCO, TX, 75034
- Phone: (617) 276-4715

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Errik Anderson | Director | Cambridge, MA |
| Hemanta Baruah | Director | Frisco, TX |
| George Robert Mabry III | Director | Frisco, TX |
| Christopher Pacheco | Director | Frisco, TX |
| Hemanta Baruah | Executive Officer | Frisco, TX |

## More

- [CIK 2030720 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2030720&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002030720-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.